Skip to main content
. 2020 Apr 16;15:150. doi: 10.1186/s13018-020-01648-z

Table 5.

Growth factors (x¯±s)

Item Experimental group (n = 66) Control group (n = 40) t P
TGF-β (μg/L)
 Before treatment 22.07 ± 2.16 21.93 ± 2.08 0.328 0.744
 After treatment 30.15 ± 3.04ab 25.42 ± 2.47a 8.313 0.000
IGF-1 (μg/L)
 Before treatment 83.41 ± 10.29 82.87 ± 9.83 0.266 0.791
 After treatment 95.72 ± 12.06ab 89.64 ± 11.25a 2.579 0.011
FGF-2 (ng/L)
 Before treatment 23.58 ± 2.47 24.01 ± 2.53 0.861 0.391
 After treatment 34.64 ± 3.59ab 28.39 ± 2.92a 9.298 0.000

Compared with before treatment, aP < 0.05; compared with control group, bP < 0.05. FGF-2 fibroblast growth factor-2, IGF-1 insulin-like growth factor-1, TGF-β transforming growth factor-β